» Articles » PMID: 20173259

Disparities Associated with Advanced Prostate Cancer Stage at Diagnosis

Overview
Date 2010 Feb 23
PMID 20173259
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

This study expands on a previous report (focusing on health insurance status and race/ethnicity) to present effects of age, socioeconomic status, hospital type, and other factors (e.g., type of Medicaid and Medicare coverage, insurance-by-race/ethnicity interactions) on advanced-stage (III/IV) at prostate cancer diagnosis. Invasive (Stages I-IV) prostate cancer cases diagnosed during 1998-2004 were extracted from the National Cancer Database (N=687,464). Independent of health-insurance and race/ethnicity, socioeconomic status was a significant predictor of advanced stage at diagnosis, with patients residing in areas with lower socioeconomic characteristics having significantly increased odds. Those treated at community-cancer-centers had significantly decreased odds (versus teaching/research-facilities). Significantly increased odds were also observed among uninsured-Blacks, Medicare-insured-Blacks, Medicaid-insured-Blacks, Medicare-insured-Hispanics, and Medicare-insured-other-racial/ethnic-minorities 65 years old and older (versus corresponding White-populations). The impact of prostate cancer screening on reducing mortality remains debatable. Still, our results suggest improvements in multiple factors that affect access-to-care may achieve earlier diagnosis and, therefore, a potentially more treatable disease.

Citing Articles

Symptom appraisal and help seeking in males with symptoms of possible prostate cancer: a qualitative study with an ethnically diverse sample in London.

Shaw B, Walter F, Hamilton W, Martins T Br J Gen Pract. 2023; 73(732):e502-e510.

PMID: 37253629 PMC: 10242866. DOI: 10.3399/BJGP.2022.0554.


Racial Differences in Incident Genitourinary Cancer Cases Captured in the National Cancer Database.

Wolff D, Monaghan T, Gordon D, Michelson K, Jones T, Khargi R Medicina (Kaunas). 2021; 57(7).

PMID: 34209546 PMC: 8303448. DOI: 10.3390/medicina57070671.


Epidemiological Determinants of Advanced Prostate Cancer in Elderly Men in the United States.

Jayasekera J, Onukwugha E, Cadham C, Tom S, Harrington D, Naslund M Clin Med Insights Oncol. 2019; 13:1179554919855116.

PMID: 31263375 PMC: 6595651. DOI: 10.1177/1179554919855116.


Geographical Variations in Prostate Cancer Outcomes: A Systematic Review of International Evidence.

Dasgupta P, Baade P, Aitken J, Ralph N, Chambers S, Dunn J Front Oncol. 2019; 9:238.

PMID: 31024842 PMC: 6463763. DOI: 10.3389/fonc.2019.00238.


Technical Feasibility of Tissue Microarray (TMA) Analysis of Tumor-Associated Immune Response in Prostate Cancer.

Wallace T, Qian J, Avital I, Bay C, Man Y, Wellman L J Cancer. 2018; 9(12):2191-2202.

PMID: 29937939 PMC: 6010688. DOI: 10.7150/jca.22846.